Emcure Pharmaceuticals Ltd Half Yearly Results

Gross Sales

4,078.88

3,817.12

3,439

3,219.25

Excise Duty

0

0

0

0

Net Sales

4,078.88

3,817.12

3,439

3,219.25

Other Operating Income

0

0

0

0

Other Income

8.17

59.1

40.68

16.31

Total Income

4,087.04

3,876.22

3,479.68

3,235.56

Total Expenditure

3,332.06

3,099.93

2,840.73

2,597.73

PBIDT

754.98

776.28

638.95

637.83

Interest

70.8

104.98

126.13

111.01

PBDT

684.18

671.3

512.82

526.82

Depreciation

193.64

190.49

174.96

137.45

Minority Interest Before NP

0

0

0

0

Tax

150.48

141.67

104.34

105.3

Deferred Tax

-13.28

-15

-7.26

-2.73

Reported Profit After Tax

353.33

354.14

240.77

286.8

Minority Interest After NP

10.65

15.49

12.15

17.24

Net Profit after Minority Interest

342.68

338.65

228.62

269.56

Extra-ordinary Items

-10.38

0

-6.8

-2.29

Adjusted Profit After Extra-ordinary item

353.06

338.65

235.42

271.85

EPS (Unit Curr.)

18.08

18.33

12.62

14.91

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

0

0

0

0

Equity

189.48

189.1

181.15

180.85

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

18.5

20.33

18.57

19.81

PBDTM(%)

-

-

-

-

PATM(%)

8.66

9.27

7

8.9